
13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE
- 申请号:EP20070816496
- 专利类型:EP
- 申请(专利权)人:中国科学院上海药物研究所
- 公开(公开)号:EP2070926(B1)
- 公开(公开)日:2011.09.07
- 法律状态:
- 出售价格: 面议 立即咨询
专利详情
专利名称 | 13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE | ||
申请号 | EP20070816496 | 专利类型 | EP |
公开(公告)号 | EP2070926(B1) | 公开(授权)日 | 2011.09.07 |
申请(专利权)人 | 中国科学院上海药物研究所 | 发明(设计)人 | HU, LIHONG;YE, JIMING;LI, JINGYA;JAMES, DAVID, E;KRAEGEN, EDWARD, W;ZHANG, HANKUN;CHENG, ZHE;LI, JIA |
主分类号 | C07D455/03 | IPC主分类号 | C07D455/03;A61K31/4375;A61P3/04;A61P3/06;A61P3/10 |
专利有效期 | 13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE 至13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE | 法律状态 | |
说明书摘要 | The present invention provides 13,13a-dihydroberberine derivatives or their physiologically acceptable salts represented by the following formula, pharmaceutical compositions comprising the same, and uses thereof. The 13,13a-dihydroberberine derivatives have an activity of promoting glucose absorption in muscle cells, and the whole animal tests show that the present compounds have effects on improving glucose-tolerance and insulin-resistance, facilitating weight loss, relieving fatty liver and the like. Thus, the present compounds can be used in treating diabetes mellitus, adiposity, fatty liver and complications thereof induced by insulin resistance. |
交易流程
-
01
选取所需
专利 -
02
确认专利
可交易 - 03 签订合同
- 04 上报材料
-
05
确认变更
成功 - 06 支付尾款
- 07 交付证书
过户资料
平台保障
1、源头对接,价格透明
2、平台验证,实名审核
3、合同监控,代办手续
4、专员跟进,交易保障
- 用户留言
暂时还没有用户留言